Pharma companies have lagged behind other businesses in adopting newer tech trends, said one executive who was recruited by GloxoSmithKline from Korean technology conglomerate Samsung.
In an interview with CNBC, Mark Ramsey, a chief data officer at Samsung who now holds the same position at GSK, said technology professionals can help pharma companies build machine learning tools that could rapidly analyze health information and clinical trial data.
The news service site has found that pharma companies like GSK and Johnson & Johnson have been actively attracting tech talent from companies such as Google and Microsoft’s LinkedIn.
For instance, Mark Leibowitz, who is leading the digital transformation at J&J as the company’s head of health of technology, came from a series of tech giants before landing at the multinational pharmaceutical and medical devices company last year.
Leibowitz has served as vice-president of platforms for file hosting service Dropbox. Before that, he was the chief business officer at Web discovery engine StumbleUpon. He was also senior director of strategic partnerships at Google Inc.
Oliver Hsiang, vice-president and global head of health technology at J&J, also came from the tech sector.
Before, joining the company this year, Hsiang was VP of partnership at Lyft. He transferred to the ride-sharing company in 2014 following a one-year stint as director of partnerships at LinkedIn.
Like Leibowitz, Hsiang also worked at StumbleUpon and Google.
Ramsey said pharmaceutical firms need to build more awareness in the tech community that they are looking for engineers and product managers. At Samsung, he is out to hire more tech talent and assure them that a lack of health background would not be a problem.